Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed 4 insider transactions across 1 company since April 2026.
Most recent transaction: a transaction of 9477719 shares of Kailera Therapeutics, Inc. ($KLRA) on April 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Common Stock | 9477719 | $0.00 | 9,477,720.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Common Stock | 2034133 | $0.00 | 2,034,134.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Series A-2 convertible preferred stock | 4968789 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | TenPercentOwner | C | Series A-2 convertible non-voting preferred stock | 708814 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |